|
Tralokinumab does not significantly reduce asthma exacerbations
Healio The analysis included 452 adults aged 18 to 75 years with severe uncontrolled asthma. Researchers randomly assigned patients to receive either 300 mg of tralokinumab every 2 weeks for 50 weeks (n = 150), every 2 weeks for 12 weeks and then every 4 … |
View full post on asthma – Google News